An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00109148
Recruitment Status : Completed
First Posted : April 25, 2005
Last Update Posted : September 9, 2015
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.

Brief Summary:
The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with obesity (considerably overweight).

Condition or disease Intervention/treatment Phase
Obesity Drug: MK0364 Phase 2

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 500 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: A Study to Assess the Safety and Efficacy of MK0364 in Obese Patients
Study Start Date : July 2004
Actual Primary Completion Date : January 2005
Actual Study Completion Date : February 2005

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients who are obese (considerably overweight) based on body mass index.

Exclusion Criteria:

  • Patients with serious or unstable current or past medical conditions

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00109148

Sponsors and Collaborators
Merck Sharp & Dohme Corp.
Study Director: Medical Monitor Merck Sharp & Dohme Corp.

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Merck Sharp & Dohme Corp. Identifier: NCT00109148     History of Changes
Other Study ID Numbers: 0364-006
First Posted: April 25, 2005    Key Record Dates
Last Update Posted: September 9, 2015
Last Verified: September 2015

Keywords provided by Merck Sharp & Dohme Corp.:
Obesity and obesity-related medical conditions

Additional relevant MeSH terms:
Nutrition Disorders
Body Weight
Signs and Symptoms